Court of Justice 13 March 2014, Case C-512/12: Judgment of the Court (First Chamber) of 13 March 2014 (request for a preliminary ruling from the Conseil d’État — France) — Octapharma France SAS v Agence nationale de sécurité du médicament et des produits de santé (ANSM), Ministère des Affaires sociales et de la Santé (Approximation of laws  — Directive 2001/83/EC  — Directive 2002/98/EC  — Scope  — Labile blood product  — Plasma prepared by means of an industrial process  — Simultaneous or exclusive application of the directives  — Option for a Member State to provide for a less rigorous regime for plasma than for medicinal products)

Also known as